Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Lochlomond, owned by Marton Szoke, has acquired majority share in Ubichem Research, a provider of chemistry services to the drug development sector, through Ubichem Pharma Services.
Subscribe to our email newsletter
The remaining minority share of Ubichem Research remains in the ownership of Jozsef Repasi, managing director of Ubichem Research.
Following the acquisition, Ubichem Pharma Services will continue to support the drug development programs of its pharma and biotech clients worldwide, from discovery through the clinic.
Repasi said they have come a long way since Ubichem Research was founded in 1996, and this step will facilitate ambitious plans for further growth of their business, and enable them to provide an even better service to their customers.